Exfoliated Cells, Bioactive Food Components, and Cancer (R21)

The summary for the Exfoliated Cells, Bioactive Food Components, and Cancer (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Exfoliated Cells, Bioactive Food Components, and Cancer (R21)
	CFDA Number:	93.399
	CFDA Description:	Cancer Control
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-08-031
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Nov 26, 2007
	Creation Date:	Dec 05, 2008
	Original Closing Date for Applications:	Jan 07, 2011
	Current Closing Date for Applications:	Jan 07, 2011
	Archive Date:	Feb 07, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Regional Organization
Grant Description: Purpose. The National Cancer Institute (NCI) invites applications for new R21 grants that focus on research to critically evaluate the use of exfoliated cells to monitor the physiological effects of dietary bioactive food components thought to be involved with cancer prevention. The objective is to encourage interdisciplinary collaborations between scientists engaged in research using exfoliated cells and those conducting nutrition research related to cancer prevention. This research will help determine the utility of exfoliated cells as a model system to monitor both the absorption and retention of bioactive food components and the concomitant alterations in genomic and epigenetic events that occur in intact cells. Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-030, that solicits applications under the NIH Research Project Grant (R01) mechanism. The R21 grant is not renewable. Funds Available and Anticipated number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over an R21 2-year period, with no more than $200,000 in direct costs allowed in any single year. Eligible organizations: Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organizations (Other than Small Business); State Governments; U.S. Territory or Possession; Non-Domestic (non-U.S.) Entity (Foreign Organization); Regional Organization; Eligible agencies of the Federal government Eligible Project Directors/Principal Investigators (PDs/PIs): Any individuals from the applicant institutions who have the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Renewals. R21 awards are not renewable. Resubmissions. Up to two resubmissions (formerly revisions/amendments") of a previously reviewed R21 grant application may be submitted. Application and Submission Information: Applicants may submit more than one application, provided each application is scientifically distinct.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-08-031.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Limited Competition: Strengthening Behavioral and Social Science in Medical School Education (R25); • Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21...; • Scientific Meetings for Creating Interdisciplinary Research Teams (R13); • Epigenetic Approaches in Cancer Epidemiology (R21); • Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21); • EXPLORATORY GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL; • Decision Making in Cancer: Single-Event Decisions; • Small Grants for Behavioral Research in Cancer Control (R03); • CANCER SURVEILLANCE USING HEALTH CLAIMS-BASED DATA SYSTEM; • STUDIES OF THE ECONOMICS OF CANCER PREVENTION, SCREENING, AND CARE